Now that #SFAF2019 is over and I have a few days to relax in sunny Santa Fe NM, I took some time to do a little reading and writing on some topics I’ve had on my mind lately. Recently at #SFAF2019, I had a chat with a colleague about the size and scope of the microbiome market. I was surprised they didn’t realize how rapidly this space was growing, and how many companies are operating in this space with specific solutions and products for both B2B and B2C markets.
I’ve done a ton of analysis on this topic (far more than just the simple list that is below) – but suffice to say that (depending on your math) there’s well over a billion of dollars of investment funding (VC and otherwise) pouring into this space. The list below includes many startups, as well as larger ones that are either already offering services or products specifically for the microbiome market or making investments in developing new ones.
By no means is this a complete list – I know I probably missed some. Leave a comment and let me know if I’ve missed something. ANd yes – I probably should break these companies into separate categories too, but that would be for a post on another day. The list below includes commerical organizations that produce or are developing therapeutics, diagnostics, B2B and B2C products or services specialized in the microbiome space.
It’s hard to keep up with all of them…
Advanced Biological Laboratories (ABL)
American Gut Project
Clinical Metagenomics A/S
Dupont Nutrition & Health
Genome & Company
Leucine Rich Bio
Metagenome Analytics, LLC
Who have I missed?